Pharmaceutical Preparation Manufacturing

NAICS Category 325412 (Pharmaceutical Preparation Manufacturing) encompasses the production and distribution of pharmaceutical preparations, including prescription and over-the-counter medications in various forms such as tablets, capsules, injectable solutions, and topical treatments. The category covers the manufacturing of radiopharmaceuticals, medical isotopes, specialized drug therapies, and related pharmaceutical compounds used in medical diagnostics and treatment. These products span diverse therapeutic areas including oncology, neurology, cardiovascular health, and rare disease management.

Recent federal contract awards in this category demonstrate significant procurement activities across multiple federal healthcare agencies, particularly the Department of Veterans Affairs (VA), Defense Health Agency, and Bureau of Prisons. Contract values range from approximately $10,000 to over $5 million, with typical contract durations spanning one base year and four option years. Frequently awarded entities include McKesson Corporation, Bristol-Myers Squibb, Merck Sharp & Dohme, and various radiopharmaceutical manufacturers like Progenics Pharmaceuticals and GE Healthcare. Most awards are unrestricted, though some utilize small business set-asides, with delivery order and purchase order formats predominating. Performance locations are primarily federal medical facilities nationwide, including VA medical centers, military treatment facilities, and federal correctional institutions.

Recent federal contract opportunities within this NAICS category focus on procuring specific pharmaceutical products for various government healthcare systems. Solicitations include requirements for medications such as Nadolol tablets, Metformin IR tablets, Lansoprazole capsules, and radiopharmaceutical isotopes. Federal agencies posting opportunities include the Department of Veterans Affairs, Department of Defense, Centers for Disease Control and Prevention, and Bureau of Prisons. Most opportunities are unrestricted or small business set-aside, with competitive procurement approaches targeting pharmaceutical manufacturers and distributors capable of meeting stringent regulatory and delivery requirements. Typical procurement scopes involve multiple tablet strengths, varying annual quantities, and distribution through established pharmaceutical prime vendor programs.